RANK

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Total US Prescription Market

Pfizer
Merck & Co
Astrazeneca Corp
Novartis
Lilly
Roche
Teva Pharma
GlaxoSmithKline
Johnson & Johnson
Amgen Corporation
Abbott
Sanofi Aventis
Bristol-Myers Squibb
Boehringer Ingelheim
Takeda
Forest Lab
Mylan Labs, Inc.
Gilead Sciences
Otsuka America
Eisai Corp

2010
307.4
26.2
18.8
18.3
15.7
14.3
13.8
13.7
13.6
12.9
12.7
10.8
10.4
9.7
6.4
6.0
4.7
4.7
4.7
4.6
4.6

Top Corporations by U.S. Sales

US$ in Billions
2009
2008
2007
300.3
285.7
280.5
27.8
27.7
31.4
19.8
20.1
21.9
18.3
16.1
15.2
13.2
11.9
13.2
13.2
12.0
10.7
14.2
12.6
11.9
12.1
11.2
9.8
15.0
16.3
17.9
12.8
15.6
15.9
12.5
12.8
13.6
10.6
10.7
10.3
11.2
10.7
10.6
9.0
8.0
6.8
7.6
6.3
5.7
7.9
7.9
7.6
4.4
4.0
3.8
3.9
3.3
3.5
3.9
3.1
2.3
4.0
3.0
2.3
4.4
3.9
3.6

2006
270.3
34.2
20.6
14.5
13.3
9.7
10.2
9.0
18.4
15.7
14.2
10.2
10.7
6.3
5.5
7.0
3.5
3.1
1.5
1.9
3.3

Copyright IMS HEALTH, a healthcare information company

'Source: IMS National Sales Perspectives
Report reflects Prescription-bound products including Insulins (and excludes other products such as OTC)
IMS routinely updates its market audits, which can and does result in changes to previously reported market size and growth rates.
Updated April 7, 2011